PROACT EU-Response project partners will attend the International Clinical Trials Methodology Conference 2026, a platform to present and discuss innovation in clinical trials methodology. During the conference, project partners will present a poster titled ‘EU-SyndAct, An Adaptive Umbrella Platform Protocol with Built-In Pandemic Pivot Capability’. EU-SyndAct (European Syndromic Adaptive Clinical Trial) is a large European ...
PROACT EU-Response will be represented at the International Society for Clinical Biostatistics Conference 2026, held jointly with the Annual Conference of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS). The event aims to highlight the opportunities created by advances in artificial intelligence and data science for methodological developments into improved biomedical research and healthcare. ...
PROACT EU-Response will attend the Cochrane Colloquium 2026, which brings together researchers, healthcare professionals, policymakers, and patients to discuss the future of evidence generation, synthesis, and use, with a focus on advancing trustworthy, transparent, and inclusive health evidence. At the conference, the project will present COSAVRI, its development for a core outcome set for pharmacological ...
Duration:
2025-2030
Coordinator:
ANRS MIE / Inserm
This project has received funding from the European Union’s Horizon Europe research and innovation program under grant agreement No 101156304
